Evolent Health Stock Alpha and Beta Analysis

EVH Stock  USD 13.26  0.33  2.55%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Evolent Health. It also helps investors analyze the systematic and unsystematic risks associated with investing in Evolent Health over a specified time horizon. Remember, high Evolent Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Evolent Health's market risk premium analysis include:
Beta
(0.90)
Alpha
(0.93)
Risk
6.8
Sharpe Ratio
(0.16)
Expected Return
(1.09)
Please note that although Evolent Health alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Evolent Health did 0.93  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Evolent Health stock's relative risk over its benchmark. Evolent Health has a beta of 0.90  . As the market becomes more bullish, returns on owning Evolent Health are expected to decrease slowly. On the other hand, during market turmoil, Evolent Health is expected to outperform it slightly. As of now, Evolent Health's Price Book Value Ratio is increasing as compared to previous years. The Evolent Health's current Price Fair Value is estimated to increase to 3.61, while Book Value Per Share is projected to decrease to 9.12.

Evolent Health Quarterly Cash And Equivalents

184.54 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Evolent Health Backtesting, Evolent Health Valuation, Evolent Health Correlation, Evolent Health Hype Analysis, Evolent Health Volatility, Evolent Health History and analyze Evolent Health Performance.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

Evolent Health Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Evolent Health market risk premium is the additional return an investor will receive from holding Evolent Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Evolent Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Evolent Health's performance over market.
α-0.93   β-0.9

Evolent Health expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Evolent Health's Buy-and-hold return. Our buy-and-hold chart shows how Evolent Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Evolent Health Market Price Analysis

Market price analysis indicators help investors to evaluate how Evolent Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evolent Health shares will generate the highest return on investment. By understating and applying Evolent Health stock market price indicators, traders can identify Evolent Health position entry and exit signals to maximize returns.

Evolent Health Return and Market Media

The median price of Evolent Health for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 26.34 with a coefficient of variation of 26.67. The daily time series for the period is distributed with a sample standard deviation of 6.54, arithmetic mean of 24.53, and mean deviation of 5.13. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of 2569 shares by Aammaad Shams of Evolent Health at 34.41 subject to Rule 16b-3
09/06/2024
2
Evolent Health Inc Stock Price Down 3.83 percent on Sep 23
09/23/2024
3
Evolent Health Reports Next Week What to Know Ahead of the Release
10/31/2024
4
Evolent Health Non-GAAP EPS of 0.04 misses by 0.30, revenue of 621.4M misses by 5.75M
11/07/2024
5
Evolent Health Inc Q3 2024 Earnings Call Highlights Navigating Medical Cost Challenges ...
11/08/2024
6
Evolent Health Stock Price Down 3.8 percent Following Analyst Downgrade
11/13/2024
7
Evolent Healths SWOT analysis stock faces headwinds amid growth potential
11/14/2024
8
Granahan Investment Management Reduces Stake in Castle Biosciences Inc
11/15/2024
9
Evolent Health Inc Stock Price Down 4.77 percent on Nov 20
11/20/2024
10
Evolent Health Inc Stock Price Up 4.26 percent on Nov 26
11/26/2024

About Evolent Health Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Evolent or other stocks. Alpha measures the amount that position in Evolent Health has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 (projected)
Dividend Yield0.0056570.0051140.007152
Price To Sales Ratio1.951.871.78

Evolent Health Upcoming Company Events

As portrayed in its financial statements, the presentation of Evolent Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Evolent Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Evolent Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Evolent Health. Please utilize our Beneish M Score to check the likelihood of Evolent Health's management manipulating its earnings.
28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Evolent Health

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:
Check out Evolent Health Backtesting, Evolent Health Valuation, Evolent Health Correlation, Evolent Health Hype Analysis, Evolent Health Volatility, Evolent Health History and analyze Evolent Health Performance.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Evolent Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Evolent Health technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Evolent Health trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...